Market revenue in 2023 | USD 8.4 million |
Market revenue in 2030 | USD 17.3 million |
Growth rate | 10.9% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 58.33% in 2023. Horizon Databook has segmented the Turkey deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Rising awareness about treatment options for neurological diseases and improvements in clinical development framework of emerging economies are expected to drive the market growth in Turkey.
Moreover, rising prevalence of neurodegenerative & psychiatric disorders coupled with unmet demand for effective & long-term treatment solutions is expected to present lucrative growth opportunities for key players operating in the market.
Hospitals, rehabilitation centers, and nonprofit organizations are collectively taking efforts to raise awareness about PD challenges and treatment availability. For instance, Health Renova Hospital and School of Physical Therapy and Rehabilitation Center in Turkey are consistently focusing on organizing health awareness campaigns and offering proper care to patients.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account